Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Mallinckrodt
Novartis
Baxter
Cerilliant
Express Scripts
Cipla
Cantor Fitzgerald
Accenture
UBS

Generated: August 20, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050742

« Back to Dashboard
NDA 050742 describes STROMECTOL, which is a drug marketed by Merck Sharp Dohme and is included in one NDA. It is available from two suppliers. Additional details are available on the STROMECTOL profile page.

The generic ingredient in STROMECTOL is ivermectin. There are five drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the ivermectin profile page.

Summary for NDA: 050742

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antiparasitics
Formulation / Manufacturing:see details

Pharmacology for NDA: 050742

Suppliers and Packaging for NDA: 050742

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
STROMECTOL
ivermectin
TABLET;ORAL 050742 NDA Merck Sharp & Dohme Corp. 0006-0032 0006-0032-20 2 BLISTER PACK in 1 CARTON (0006-0032-20) > 10 TABLET in 1 BLISTER PACK
STROMECTOL
ivermectin
TABLET;ORAL 050742 NDA Department of State Health Services, Pharmacy Branch 55695-019 55695-019-00 2 BLISTER PACK in 1 CARTON (55695-019-00) > 10 TABLET in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength6MG
Approval Date:Nov 22, 1996TE:RLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength3MG
Approval Date:Oct 8, 1998TE:ABRLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Novartis
Johnson and Johnson
Teva
Merck
Julphar
Cipla
Queensland Health
QuintilesIMS
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot